TrialJournal of substance abuse treatment2019

Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.

Elizabeth A Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.